Amy Bachrodt insider trades: Maze Therapeutics (MAZE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Amy reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | MAZE | ↓ Sell | 2,500 | $29.44 | $74K | Direct | Apr 2, 2026 (1d) |
| Feb 2, 2026 | MAZE | ↓ Sell | 5,000 | $46.04 | $230K | Direct | Feb 4, 2026 (2d) |
| Jan 2, 2026 | MAZE | ↓ Sell | 5,000 | $39.15 | $196K | Direct | Jan 6, 2026 (4d) |
| Dec 30, 2025 | MAZE | ↓ Sell | 15,000 | $40.41 | $606K | Direct | Dec 31, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MAZE insiders
Open-market trades in the last 12 months
About Amy Bachrodt's insider trades
Amy Bachrodt is SVP, Finance at Maze Therapeutics (MAZE). Since Dec 30, 2025, Amy has reported no open-market purchases and 4 sales worth $1.1M on SEC Form 4. In the last 12 months: 4 sales ($1.1M).
Their filings also include option exercises (4 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAZE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.